AWH have several key catalysts that will drive this stock to new 52 week highs and they should be all around upcoming earnings call in early-mid August.
1.) Announcement of a major doctor network (up to 3500) that will be utilizing OVA1 in their practices and as the SOC for testing Ovarian cancer.
2.) Announcement of a partnership with a major player (possibly Abbvie) for endometriosis test and other collaborations.
3,) Earnings call with forward guidance showing substantial growth.
Big accumulation of stock over last several months and now a nice consolidation pattern in that $3.75-$4.50 range. We should break out shortly (next two weeks) and obviously any of the above news events will be a catalyst to take us to new highs.
This company will be bought out by Quest Diagnostics, Roche or some other large entity in the healthcare space now that insurance is in place.
News 
Market Data 
Discover 
